Literature DB >> 27965059

Epigenetics of psoriatic disease: A systematic review and critical appraisal.

Remy A Pollock1, Fatima Abji2, Dafna D Gladman3.   

Abstract

Psoriasis is an inflammatory disease of the skin that is sometimes accompanied by an auto-inflammatory arthritis called psoriatic arthritis (PsA). Psoriasis and PsA are multifactorial diseases that result from complex interactions of environmental and genetic risk factors. Epigenetic marks, which are labile chemical marks with diverse functions, form a layer of biological information that sits at the interface of genetics and the environment. Aberrant epigenetic regulation has been previously implicated in other rheumatological disorders. The purpose of this review is to summarize and critically evaluate the nascent literature on epigenetics in psoriasis and PsA. A systematic review yielded 52 primary articles after applying inclusion and exclusion criteria. Data were extracted using a standardized template and study quality assessed using a methodological quality checklist. Studies reflect a broad range of epigenetic sub-disciplines, the most common being DNA methylation, followed by the parent of origin effect or genomic imprinting, expression or activity of epigenetic modifying enzymes, and histone modifications. Epidemiological studies demonstrating excessive paternal transmission provided the earliest evidence of epigenetic deregulation in psoriatic disease, however few studies have examined its molecular mechanisms. Methylation studies evolved rapidly from low resolution global to targeted analyses of known psoriatic disease susceptibility loci such as HLA-C*0602. The recent explosion of epigenome-wide association studies has provided us with novel insights into psoriasis pathogenesis, and the mechanism of action of UVB, methotrexate, and anti-TNF therapies, as well as molecular signatures of psoriasis that may have clinical relevance. Finally, recent studies of pharmacological inhibitors of epigenetic modifier enzymes demonstrate their potential applicability as novel treatment modalities for psoriasis. Challenges of epigenetics research in psoriasis and PsA were identified and future perspectives are discussed herein.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DNA methylation; Epigenetics; Histone modifications; Parent-of-origin effect; Psoriasis; Psoriatic arthritis

Mesh:

Substances:

Year:  2016        PMID: 27965059     DOI: 10.1016/j.jaut.2016.12.002

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  26 in total

1.  DNA methylation-based subclassification of psoriasis in the Chinese Han population.

Authors:  Fusheng Zhou; Changbing Shen; Yi-Hsiang Hsu; Jing Gao; Jinfa Dou; Randy Ko; Xiaodong Zheng; Liangdan Sun; Yong Cui; Xuejun Zhang
Journal:  Front Med       Date:  2018-04-05       Impact factor: 4.592

Review 2.  Molecular mechanisms of mechanotransduction in psoriasis.

Authors:  Lina S Malakou; Antonios N Gargalionis; Christina Piperi; Evangelia Papadavid; Athanasios G Papavassiliou; Efthimia K Basdra
Journal:  Ann Transl Med       Date:  2018-06

Review 3.  Epigenetics in Non-tumor Immune-Mediated Skin Diseases.

Authors:  M C Ovejero-Benito; E Daudén; Alejandra Reolid; E Muñoz-Aceituno; F Abad-Santos
Journal:  Mol Diagn Ther       Date:  2021-03-01       Impact factor: 4.074

4.  Biological therapy downregulates the heterodimer S100A8/A9 (calprotectin) expression in psoriatic patients.

Authors:  F D'Amico; M Granata; E Skarmoutsou; C Trovato; G Lovero; P Gangemi; V Longo; M Pettinato; M C Mazzarino
Journal:  Inflamm Res       Date:  2018-03-31       Impact factor: 4.575

Review 5.  Autoimmunity in 2017.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

Review 6.  Mold and Human Health: a Reality Check.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

Review 7.  Autoimmunity in 2016.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

8.  Increased presence and differential molecular imprinting of transit amplifying cells in psoriasis.

Authors:  Katrin Witte; Karsten Jürchott; Demetrios Christou; Jochen Hecht; Gabriela Salinas; Ulrike Krüger; Oliver Klein; Georgios Kokolakis; Ellen Witte-Händel; Rotraut Mössner; Hans-Dieter Volk; Kerstin Wolk; Robert Sabat
Journal:  J Mol Med (Berl)       Date:  2019-12-12       Impact factor: 4.599

Review 9.  Psoriasis and Genetics.

Authors:  Nick Dand; Satveer K Mahil; Francesca Capon; Catherine H Smith; Michael A Simpson; Jonathan N Barker
Journal:  Acta Derm Venereol       Date:  2020-01-30       Impact factor: 3.875

10.  Anti-tumor necrosis factor drug responses and skin-blood DNA methylation age: Relationships in moderate-to-severe psoriasis.

Authors:  Jamaji C Nwanaji-Enwerem; Ugoji Nwanaji-Enwerem; Andrea A Baccarelli; Ramone F Williams; Elena Colicino
Journal:  Exp Dermatol       Date:  2020-10-17       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.